Multiple Mechanisms of Shenqi Pill in Treating Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking

Table 1

Active compounds of SQP against NAFLD.

Mol ID	Ingredient	Degree	OB (%)	DL
MOL000098	Quercetin	41	54.83	0.24
MOL000422	Kaempferol	22	65.31	0.35
MOL000449	Stigmasterol	10	43.87	0.76
MOL000546	Diosgenin	5	43.78	0.76
MOL008457	Tetrahydroalstonine	4	32.42	0.81
MOL002392	Deltoin	4	46.69	0.37
MOL000358	Beta-sitosterol	3	36.91	0.75
MOL000492	(+)-Catechin	2	42.36	0.37
MOL004576	Taxifolin	2	57.84	0.27
MOL000322	Kadsurenone	1	37.57	0.71
MOL005440	Isofucosterol	1	38.16	0.54
MOL005430	Hancinone C	1	61.47	0 38
MOL007374	5- ((5- (4-methoxyphenyl)-2furyl)methylene)Barbiturc acid	1	31.14	0.54
MOL001559	Piperlonguminine	1	60.51	0.27
MOL003137	Leucanthoside MOL005440	1	32.12	0.78